Skip to main content

Advertisement

Log in

Trajectories of switching to optimise efficacy and minimising risks in patients with moderate-to-severe plaque psoriasis: results from the PsoReal registry

  • Research Letter
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Data availability

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to the privacy or ethical restrictions.

References

  1. Mrowietz U, de Jong EM, Kragballe K et al (2014) A consensus report on appropriate treatment optimization and transitioning in the management of moderate-to-severe plaque psoriasis. J Eur Acad Dermatol Venereol 28(4):438–453. https://doi.org/10.1111/jdv.12118

    Article  CAS  PubMed  Google Scholar 

  2. Armstrong AW, Patel M, Li C et al (2023) Real-world switching patterns and associated characteristics in patients with psoriasis treated with biologics in the United States. J Dermatolog Treat 34(1):2200870. https://doi.org/10.1080/09546634.2023.2200870

    Article  PubMed  Google Scholar 

  3. Özkur E, Kıvanç Altunay İ, Oğuz Topal İ et al (2021) Switching Biologics in the treatment of Psoriasis: a Multicenter experience. Dermatology 237(1):22–30. https://doi.org/10.1159/000504839

    Article  CAS  PubMed  Google Scholar 

  4. Pezzolo E, Cazzaniga S, Di Leo S, Naldi L (2022) Efficacy and safety of Dimethyl fumarate in comparison with conventional therapy for psoriasis: an Italian real-world clinical experience. J Eur Acad Dermatol Venereol 36(7):e534–e537. https://doi.org/10.1111/jdv.17997

    Article  CAS  PubMed  Google Scholar 

  5. Edmonds J (1967) Optimum branchings. Journal of Research of the National Bureau of standards. Sect B 71B:233–240

    Google Scholar 

Download references

Funding

The study received an unconditioned grant from Almirall.

Author information

Authors and Affiliations

Authors

Contributions

Conceptualization: LN; Data Curation; EP, SDL, SC; Formal analysis: SC; Funding acquisition: LN, SC; Investigation: FC; Methodology: SC; Project administration: EP; Resources: LN, EP, SC; Software: SC; Supervision: LN, EP, SC; Validation: EP, LN, SC; Visualization: SC, EP, FC; Writing-Original Draft Preparation: EP, LN; Writing, Review and Editing: EP, LN, SC.

Corresponding author

Correspondence to Elena Pezzolo.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Patient consent

No recognizable patient photographs or other identifiable material was included.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pezzolo, E., Cazzaniga, S., Cassalia, F. et al. Trajectories of switching to optimise efficacy and minimising risks in patients with moderate-to-severe plaque psoriasis: results from the PsoReal registry. Arch Dermatol Res 316, 263 (2024). https://doi.org/10.1007/s00403-024-02967-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00403-024-02967-5

Navigation